Locus Discovery Incorporated Company Profile

17:20 EDT 18th March 2018 | BioPortfolio

Locus Discovery Inc. is a privately held chemogenomics biopharmaceutical company organized in September 1999, and is based on technology exclusively licensed from the Sarnoff Corporation (SRI International). The Locus Discovery process is a novel computational approach for rapidly designing small molecule therapeutic compounds that can act as antagonists or agonists of protein activity.


201 Washington Road, 3-075
United States of America


Phone: (215) 358 2000
Fax: (215) 358 2010

News Articles [366 Associated News Articles listed on BioPortfolio]

Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials

RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2017/PRNewswire/ -- Locus Biosciences Inc., an emerging biotechnology company focused on the discovery and development of a Read more...

CRISPR/Cas3 Platform Developer Locus Biosciences Raises $19M in Series A Financing

Locus Biosciences, developer of a next-generation CRISPR /Cas platform for precision antimicrobials, has closed $19 million in Series A funding designed to fund the company through filing its first In...

Funding round raises $19M for Locus to develop CRISPR-Cas3 technology

Locus Biosciences plans to use the $19 million it raised from a Series A funding round to develop antimicrobials to combat dr -More- 

Locus on Chromosome 2 Linked to Clinical Vertebral Fractures

A novel locus on chromosome 2 is associated with clinical vertebral fractures independently of bone density, according to results from a genome-wide association study (GWAS). Reuters Health Informat...

Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs”

A growing number of companies are using CRISPR technology to try and develop more precise treatments for a wide range of diseases, and Locus Biosciences is joining the mix, embracing the platform to t...

Locus Biosciences closes $19mm Series A

Locus Biosciences Inc. (developing a next-generation CRISPR-Cas platform for antimicrobials) raised $19mm in its Series A financing led by ARTIS Ventures, which was joined by investors including Tence...

Locus coeruleus activity linked with hyperarousal in PTSD

A new study has linked signs of heightened arousal and reactivity -- a core symptom of posttraumatic stress disorder (PTSD) -- to overactivity of the locus coeruleus (LC), a brain region that mediates...

Research links locus coeruleus activity with hyperarousal in PTSD

(Elsevier) A new study in Biological Psychiatry has linked signs of heightened arousal and reactivity -- a core symptom of posttraumatic stress disorder (PTSD) -- to overactivity of the locus coeruleu...

PubMed Articles [818 Associated PubMed Articles listed on BioPortfolio]

Systematic Discovery of RNA Binding Proteins that Regulate MicroRNA Levels.

RNA binding proteins (RBPs) interact with primary, precursor, and mature microRNAs (miRs) to influence mature miR levels, which in turn affect critical aspects of human development and disease. To und...

Pedigree Analysis of Familial Primary Concomitant Horizontal Strabismus in Northern India.

Familial clustering of common forms of primary strabismus like esotropia (ET) and exotropia (XT) is observed in a proportion of the strabismus cohort. The genetic components of this remain unidentifie...

Quantitative trait locus mapping in mice identifies phospholipase Pla2g12a as novel atherosclerosis modifier.

In a previous work, a female-specific atherosclerosis risk locus on chromosome (Chr) 3 was identified in an intercross of atherosclerosis-resistant FVB and atherosclerosis-susceptible C57BL/6 (B6) mic...

Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.

The advent of locus-specific protein recruitment technologies has enabled a new class of studies in chromatin biology. Epigenome editors enable biochemical modifications of chromatin at almost any spe...

The unusual S locus of Leavenworthia is composed of two sets of paralogous loci.

The Leavenworthia self-incompatibility locus (S locus) consists of paralogs (Lal2, SCRL) of the canonical Brassicaceae S locus genes (SRK, SCR), and is situated in a genomic position that differs from...

Clinical Trials [210 Associated Clinical Trials listed on BioPortfolio]

Locus of Control and Spirituality in Palliative Care Patients

Primary Objectives: 1. To determine whether the degree of spirituality/religiosity as determined by the Duke University Religion Index and Functional Assessment of Chronic Illness ...

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population

This study is to investigate whether variants in the LOC387715 locus and the HtrA serine peptidase 1 (HTRA1) gene within the 10q26 locus are associated with polypoidal choroidal vasculopat...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Companies [1119 Associated Companies listed on BioPortfolio]

Locus Discovery Incorporated

Locus Discovery Inc. is a privately held chemogenomics biopharmaceutical company organized in September 1999, and is based on technology exclusively licensed from the Sarnoff Corporation (SRI Internat...


PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Locus Pharmaceuticals, Inc.

Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs. The foundation and competitiveness ...

Locus Genex Oy

Monoclonal Antibodies to Human Neurotransmitter Substances.manufacturer and supplier of monoclonals antibodies.

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including, as well as its Continuing Medical Education (CME) business and ...

More Information about "Locus Discovery Incorporated" on BioPortfolio

We have published hundreds of Locus Discovery Incorporated news stories on BioPortfolio along with dozens of Locus Discovery Incorporated Clinical Trials and PubMed Articles about Locus Discovery Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Locus Discovery Incorporated Companies in our database. You can also find out about relevant Locus Discovery Incorporated Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record